Literature DB >> 11673194

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers.

W J Burman1, R R Reves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11673194     DOI： 10.1164/ajrccm.164.7.2109052

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China.

Authors:  Na Xu; Jing Xiang Yang; Jian Yang
Journal:  Eur J Hosp Pharm       Date:  2020-09-28

2.  Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China.

Authors:  Penghui Shang; Yinyin Xia; Feiying Liu; Xiaomeng Wang; Yanli Yuan; Daiyu Hu; Dehua Tu; Yixin Chen; Peiyuan Deng; Shiming Cheng; Lin Zhou; Yu Ma; Lizhen Zhu; Weiwei Gao; Hongyuan Wang; Dafang Chen; Li Yang; Pingping He; Shanshan Wu; Shaowen Tang; Xiaozhen Lv; Zheng Shu; Yuan Zhang; Zhirong Yang; Yan Chen; Na Li; Feng Sun; Xiaoting Li; Yingjian He; Paul Garner; Siyan Zhan
Journal:  PLoS One       Date:  2011-07-05       Impact factor: 3.240

3.  Serum protein gamma-glutamyl hydrolase, Ig gamma-3 chain C region, and haptoglobin are associated with the syndromes of pulmonary tuberculosis in traditional Chinese medicine.

Authors:  Ting-Ting Jiang; Chong Wang; Li-Liang Wei; Xiao-Mei Yu; Li-Ying Shi; Dan-Dan Xu; Zhong-Liang Chen; Ze-Peng Ping; Ji-Cheng Li
Journal:  BMC Complement Altern Med       Date:  2015-07-22       Impact factor: 3.659

4.  Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis.

Authors:  Zenya Saito; Yugo Kaneko; Akira Kinoshita; Yusuke Kurita; Kyuto Odashima; Tsugumi Horikiri; Yutaka Yoshii; Aya Seki; Yoshitaka Seki; Hiroshi Takeda; Kazuyoshi Kuwano
Journal:  BMC Infect Dis       Date:  2016-11-11       Impact factor: 3.090

5.  Microarray expression profile analysis of mRNAs and long non-coding RNAs in pulmonary tuberculosis with different traditional Chinese medicine syndromes.

Authors:  Ting-Ting Jiang; Li-Liang Wei; Li-Ying Shi; Zhong-Liang Chen; Chong Wang; Chang-Ming Liu; Zhong-Jie Li; Ji-Cheng Li
Journal:  BMC Complement Altern Med       Date:  2016-11-17       Impact factor: 3.659

6.  Cytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohort.

Authors:  Shaowen Tang; Xiaozhen Lv; Yuan Zhang; Shanshan Wu; Zhirong Yang; Yinyin Xia; Dehua Tu; Peiyuan Deng; Yu Ma; Dafang Chen; Siyan Zhan
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

7.  Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study.

Authors:  Alima Hassen Ali; Tefera Belachew; Alemeshet Yami; Wubeante Yenet Ayen
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

8.  The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.

Authors:  Yang Xiang; Long Ma; Weidong Wu; Wei Liu; Yongguang Li; Xia Zhu; Qian Wang; Jinfeng Ma; Mingqin Cao; Qian Wang; Xuemei Yao; Lei Yang; Atikaimu Wubuli; Corinne Merle; Paul Milligan; Ying Mao; Jiayi Gu; Xiumei Xin
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

9.  Evaluation of anti-tuberculosis induced adverse reactions in hospitalized patients.

Authors:  Kheirollah Gholami; Elahe Kamali; Mahboubeh Hajiabdolbaghi; Gloria Shalviri
Journal:  Pharm Pract (Granada)       Date:  2006

10.  Drug-induced hepatotoxicity among TB/HIV co-infected patients in a referral hospital, Ethiopia.

Authors:  Abebe Zeleke; Bethelihem Misiker; Teshager Aklilu Yesuf
Journal:  BMC Res Notes       Date:  2020-01-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.